Abstract:Autophagy is a conserved lysosomal degradation pathway where cellular components are dynamically degraded and re-processed to maintain physical homeostasis. However, the physiological effect of autophagy appears to be multifaced. On the one hand, autophagy functions as a cytoprotective mechanism, protecting against multiple diseases, especially tumor, cardiovascular disorders, and neurodegenerative and infectious disease. Conversely, autophagy may also play a detrimental role via pro-survival effects on cancer cells or cell-killing effects on normal body cells. During disorder onset and progression, the expression levels of autophagy-related regulators and proteins encoded by autophagy-related genes (ATGs) are abnormally regulated, giving rise to imbalanced autophagy flux. However, the detailed mechanisms and molecular events of this process are quite complex. Epigenetic, including DNA methylation, histone modifications and miRNAs, and post-translational modifications, including ubiquitination, phosphorylation and acetylation, precisely manipulate gene expression and protein function, and are strongly correlated with the occurrence and development of multiple diseases. There is substantial evidence that autophagy-relevant regulators and machineries are subjected to epigenetic and post-translational modulation, resulting in alterations in autophagy levels, which subsequently induces disease or affects the therapeutic effectiveness to agents. In this review, we focus on the regulatory mechanisms mediated by epigenetic and post-translational modifications in disease-related autophagy to unveil potential therapeutic targets. In addition, the effect of autophagy on the therapeutic effectiveness of epigenetic drugs or drugs targeting post-translational modification have also been discussed, providing insights into the combination with autophagy activators or inhibitors in the treatment of clinical diseases.

An update on the bridging factors connecting autophagy and Nrf2 antioxidant pathway

Reactive Oxygen Species as a Link between Antioxidant Pathways and Autophagy

Redox Regulation of Autophagy in Cancer: Mechanism, Prevention and Therapy

Deconvoluting the role of reactive oxygen species and autophagy in human diseases.

Interplay among Oxidative Stress, Autophagy, and the Endocannabinoid System in Neurodegenerative Diseases: Role of the Nrf2- p62/SQSTM1 Pathway and Nutraceutical Activation

Unravelling the relationship between macroautophagy and mitochondrial ROS in cancer therapy

Mitochondrial-Endoplasmic Reticulum Communication-Mediated Oxidative Stress and Autophagy

Nrf2 Connects Cellular Autophagy and Vascular Senescence in Atherosclerosis: A Mini-Review

Autophagy: A Crucial Moderator of Redox Balance, Inflammation, and Apoptosis in Lung Disease

The Antioxidative Role of Chaperone-Mediated Autophagy as a Downstream Regulator of Oxidative Stress in Human Diseases

The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: an Update

Oxidation of multiple MiT/TFE transcription factors links oxidative stress to transcriptional control of autophagy and lysosome biogenesis

The Interrelation Between Reactive Oxygen Species and Autophagy in Neurological Disorders

Oxidative stress and autophagy: the clash between damage and metabolic needs

Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets

P62 Links Autophagy and Nrf2 Signaling

Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease

Autophagy Intertwines with Different Diseases—Recent Strategies for Therapeutic Approaches

Redox Signaling: Potential Arbitrator of Autophagy and Apoptosis in Therapeutic Response

NRF2 in age-related musculoskeletal diseases: Role and treatment prospects

p62: Intersection of Antioxidant Defense and Autophagy Pathways